ES2176001T3 - Composicion con liberacion prolongada de principio activo apta para formar una microemulsion. - Google Patents
Composicion con liberacion prolongada de principio activo apta para formar una microemulsion.Info
- Publication number
- ES2176001T3 ES2176001T3 ES99934821T ES99934821T ES2176001T3 ES 2176001 T3 ES2176001 T3 ES 2176001T3 ES 99934821 T ES99934821 T ES 99934821T ES 99934821 T ES99934821 T ES 99934821T ES 2176001 T3 ES2176001 T3 ES 2176001T3
- Authority
- ES
- Spain
- Prior art keywords
- active principle
- microemulsion
- composition
- polymeric matrix
- ingestion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Composición destinada a ser ingerida que comprende un sistema automicroemulsionable en contacto con una fase hidrófila aportada, después de ingestión, por el líquido fisiológico, comprendiendo dicho sistema automicroemulsionable: por lo menos un activo, una fase lipófila constituida por una mezcla de mono-, di- y triglicéridos con unos ácidos grasos con C8-C18 y de mono- y diésteres de polietilenglicol que presentan un balance hidrófilo/lipófilo (HLB) inferior a 16; un agente tensioactivo (TA) a base de glicéridos que presentan un HLB inferior a 16 elegido en el grupo que comprende los glicéridos poliglicosilados saturados con C8-C10 y los ésteres oleicos del poliglicerol; un agente cotensioactivo (CoTA) elegido en el grupo que comprende los ésteres de ácidos grasos del propilenglicol, los ésteres oleicos del poliglicerol, el etildiglicol; estando la relación TA-CoTA comprendida entre 0,5 y 6; caracterizada porque dicha composición comprende además una matriz polimérica inerte, que representa de 0,5 a 40 % en peso de la composición total, no ionizable a pH fisiológico, dispersada en el sistema automicroemulsionable antes de ingestión, siendo dicha matriz polimérica apta, después de ingestión, para formar, en contacto con el líquido fisiológico, una matriz polimérica gelificada que permite liberar por difusión, de forma continua y prolongada, el activo entonces microemulsionado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810313A FR2782006B1 (fr) | 1998-08-07 | 1998-08-07 | Composition a liberation prolongee apte a former une micro-emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2176001T3 true ES2176001T3 (es) | 2002-11-16 |
Family
ID=9529608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99934821T Expired - Lifetime ES2176001T3 (es) | 1998-08-07 | 1999-07-30 | Composicion con liberacion prolongada de principio activo apta para formar una microemulsion. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6309665B2 (es) |
EP (1) | EP1102581B1 (es) |
JP (1) | JP2002522379A (es) |
KR (1) | KR20010072292A (es) |
AT (1) | ATE217791T1 (es) |
AU (1) | AU5047099A (es) |
DE (1) | DE69901567T2 (es) |
ES (1) | ES2176001T3 (es) |
FR (1) | FR2782006B1 (es) |
WO (1) | WO2000007573A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2838349B1 (fr) * | 2002-04-15 | 2004-06-25 | Laurence Paris | Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication |
DE10226990A1 (de) * | 2002-06-18 | 2004-03-18 | Sanguibiotech Ag | Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff |
GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
US20040115226A1 (en) * | 2002-12-12 | 2004-06-17 | Wenji Li | Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
US20070128117A1 (en) * | 2003-02-04 | 2007-06-07 | Bracco International B.V. | Ultrasound contrast agents and process for the preparation thereof |
CA2512454C (en) | 2003-02-04 | 2012-10-30 | Bracco Research Sa | Ultrasound contrast agents and process for the preparation thereof |
CA2547024C (en) | 2003-12-22 | 2013-12-17 | Bracco Research Sa | Gas-filled microvesicle assembly for contrast imaging |
ES2425937T3 (es) * | 2004-03-24 | 2013-10-18 | Takeda Pharmaceutical Company Limited | Estabilizante de emulsión |
US20050220866A1 (en) * | 2004-04-02 | 2005-10-06 | Dr. Reddy's Laboratories Limited | Novel capsule formulations of etoposide for oral use |
WO2005105040A2 (en) * | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
EP1784228B1 (en) | 2004-08-18 | 2016-10-05 | Bracco Suisse SA | Gas-filled microvesicles composition for contrast imaging |
US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
EP2985026B1 (en) | 2005-04-15 | 2022-08-03 | Clarus Therapeutics, Inc. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
CN101360485B (zh) * | 2005-10-26 | 2013-04-17 | 班纳制药公司 | 作为胶囊填充物的基于亲水性载体的双重控释基质系统 |
US8293270B2 (en) * | 2005-10-26 | 2012-10-23 | Banner Pharmacaps, Inc. | Lipophilic vehicle-based dual controlled release matrix system |
DE102008015299A1 (de) | 2008-03-18 | 2009-09-24 | Pkh Gmbh Halle | Kolloidales Trägersystem |
SI2600850T1 (sl) | 2010-08-04 | 2018-12-31 | Gruenenthal Gmbh | Farmacevtska oblika odmerka, ki zajema 6'-fluoro-(N-metil- ali N,N- dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,B)indol)-4-amin, za zdravljenje nociceptivne bolečine |
CN102846544B (zh) * | 2011-08-29 | 2014-01-15 | 华北制药集团新药研究开发有限责任公司 | 一种难溶药物的自微乳组合物 |
DE102012019029A1 (de) | 2012-09-27 | 2014-03-27 | Alf Lamprecht | Arzneiformulierungen zur oralen Gabe von therapeutischen Substanzen und Verfahren zur Herstellung |
WO2015100406A1 (en) | 2013-12-26 | 2015-07-02 | Clarus Therapeutics, Inc. | Use of oral pharmaceutical products combining testosterone esters with hypolipidemic agents |
US10245034B2 (en) * | 2015-08-31 | 2019-04-02 | Ethicon Llc | Inducing tissue adhesions using surgical adjuncts and medicants |
US10569071B2 (en) | 2015-08-31 | 2020-02-25 | Ethicon Llc | Medicant eluting adjuncts and methods of using medicant eluting adjuncts |
KR101679380B1 (ko) * | 2015-09-10 | 2016-11-25 | 주식회사 유유제약 | 두타스테리드를 포함하는 약학적 조성물 및 이를 포함하는 캡슐 제형 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
FR2629363B1 (fr) * | 1988-03-29 | 1991-10-11 | Rubinstein Inc H | Particules d'emulsion gelifiees et leur utilisation, notamment en cosmetologie |
GB9022788D0 (en) * | 1990-10-19 | 1990-12-05 | Cortecs Ltd | Pharmaceutical formulations |
US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
FR2710535B1 (fr) * | 1993-09-30 | 1995-11-24 | Gattefosse Ets Sa | Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion. |
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
FR2748209B1 (fr) * | 1996-05-06 | 1998-06-05 | Adir | Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs |
US5993858A (en) * | 1996-06-14 | 1999-11-30 | Port Systems L.L.C. | Method and formulation for increasing the bioavailability of poorly water-soluble drugs |
BE1011363A3 (fr) * | 1997-09-11 | 1999-08-03 | Smb Technology | Capsules semi-solides autoemulsionnables matricielles a action prolongee. |
-
1998
- 1998-08-07 FR FR9810313A patent/FR2782006B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-30 EP EP99934821A patent/EP1102581B1/fr not_active Expired - Lifetime
- 1999-07-30 DE DE69901567T patent/DE69901567T2/de not_active Expired - Lifetime
- 1999-07-30 KR KR1020017001576A patent/KR20010072292A/ko not_active Application Discontinuation
- 1999-07-30 AT AT99934821T patent/ATE217791T1/de active
- 1999-07-30 AU AU50470/99A patent/AU5047099A/en not_active Abandoned
- 1999-07-30 JP JP2000563259A patent/JP2002522379A/ja active Pending
- 1999-07-30 WO PCT/FR1999/001889 patent/WO2000007573A1/fr not_active Application Discontinuation
- 1999-07-30 ES ES99934821T patent/ES2176001T3/es not_active Expired - Lifetime
-
2001
- 2001-02-02 US US09/775,782 patent/US6309665B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2782006B1 (fr) | 2002-04-19 |
US20010004459A1 (en) | 2001-06-21 |
AU5047099A (en) | 2000-02-28 |
US6309665B2 (en) | 2001-10-30 |
EP1102581A1 (fr) | 2001-05-30 |
EP1102581B1 (fr) | 2002-05-22 |
FR2782006A1 (fr) | 2000-02-11 |
DE69901567D1 (de) | 2002-06-27 |
WO2000007573A1 (fr) | 2000-02-17 |
ATE217791T1 (de) | 2002-06-15 |
KR20010072292A (ko) | 2001-07-31 |
DE69901567T2 (de) | 2002-10-31 |
JP2002522379A (ja) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2176001T3 (es) | Composicion con liberacion prolongada de principio activo apta para formar una microemulsion. | |
ATE321533T1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen | |
ES2176133T1 (es) | Envase de detergente. | |
DK0951280T3 (da) | Hydrofile mikropartikler og fremgangsmåder til fremstilling heraf | |
UY24210A1 (es) | Composicion de gel o de barra antitranspirante libre de pegajosidad, clara o translucida y metodo de fabricacion | |
HUP0300882A2 (hu) | Új önemulgeáló hatóanyag-beadási rendszer | |
PT1165053E (pt) | Formas de dosagem de dispersao rapida contendo gelatina de peixe | |
AR018573A1 (es) | Metodo para microencapsular una sustancia solida y microcapsula de una sustancia solida que tiene una capa intermedia obtenida por el mismo | |
ES2118677T1 (es) | Una composicion que comprende un agente activo disuelto en un vehiculo vitrificante y un procedimiento para su preparacion. | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
PL335575A1 (en) | Hydrophilic two-component systems for use in administration of cyclosporine | |
CA2416383A1 (en) | Solution-, dispersion- or emulsion-producing film dermatics | |
PT994727E (pt) | Processo para solubilizar ingredientes farmaceuticamente activos em agua e noutros veiculos aquosos | |
NO992908D0 (no) | Individuelt doserte folieformige administrasjonsformer som degraderer hurtig ved kontakt med vµsker og som inneholder virkestoff- og aromastoffer | |
ES2108138T3 (es) | Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada. | |
SE0004671D0 (sv) | Pharmaceutical formulation | |
AR028727A1 (es) | Una composicion detergente liquida | |
ES2179103T3 (es) | Composicion detergente. | |
DZ3473A1 (fr) | Formulation pharmaceutique a liberation prolongee independante de la force ionique. | |
ES2137635T3 (es) | Composicion liquida estable que contiene urato oxidasa y composicion liofilizada para su preparacion. | |
ZA200403803B (en) | Selective targeting of apoptotic cells. | |
DE59902797D1 (de) | Verkapseltes reinigungsmittel | |
TW200722112A (en) | Microcapsule of polyvinyl alcohol copolymer | |
AR012627A1 (es) | Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado | |
ECSP951565A (es) | Composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 1102581 Country of ref document: ES |